ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
90 hedge funds and large institutions have $114M invested in Antares Pharma, Inc. in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $143M → $114M (-$28.6M)
Holders
90
Holding in Top 10
1
Calls
$505K
Puts
$40K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$1.53M | |
| 3 | +$1.23M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$727K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$533K |
Top Sellers
| 1 | -$5M | |
| 2 | -$3.03M | |
| 3 | -$1.76M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$680K |
| 5 |
Morgan Stanley
New York
|
-$562K |